Cullen Investment Group LTD. reduced its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 60.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,740 shares of the med
Source link
Sometimes markets just refuse to do what you think they are going to do. Constantly commenting on every twist and turn the markets make is always going to end with egg on your face at some point. The rotation in markets is leading to some wild moves beneath the surface, but, in general, markets have…
Image source: Getty Images TSX investors are wondering which Canadian dividend stocks are now undervalued and good to buy for a self-directed Tax-Free Savings Account (TFSA) focused on passive income. Canadian Natural Resources Canadian Natural Resources (TSX:CNQ) picked up a new tailwind in recent days, but the stock is still down 10% in 2025 and…
The Aussie government is discussing changes to the CGT discount. That might explain some of the relatively muted reactions to earnings season across the market today. Taxes only ever go up, it seems. Meanwhile, across the Pacific, Trump has been dealt a blow to his favourite financial lever. The US Supreme Court has ruled that…
Mizuho boosted their target price on Applied Materials from $195.00 to $220.00 and gave the stock an “outperform” rating in a report on Monday. Source link
Aclaris Therapeutics (NASDAQ:ACRS) used an H.C. Wainwright inflammatory skin diseases conference fireside chat to outline development plans and differentiation points for its lead biologic candidate, ATI-052, and to provide updates on its small-molecule pipeline. ATI-052: bispecific approach and ea Source link
Unbelievable… As a tradetech/mdsnews member from way back (and being out of the market for 10yrs), I only today got access to the Bourse Data free trial in the attempt to find Market Analyser. I was disappointed to find it was not the same software, and didn’t get a response from their Support. I’ve been…